The Danish Dude
Re: Legend431 post# 703182
Tuesday, July 02, 2024 2:53:08 AM
Post#
703188
of 703209
NWBO had these milestones since October 2020 where share price was at $2.51. At that time we had 400 million LESS shares than today.
October 2020: NWBO announced the data lock for their Phase III trial of DCVax-L for Glioblastoma
December 2021: UK Manufacturing License
March 2022: Positive Top-Line Results
August 2022: Regulatory Approval for Pediatric Plan
December 2023: Submission of MAA
February 2024: Moving towards the production of GMP-compliant units?
March 2024: Board Appointment
May 2024: Nature article about results of DCvax-L in combo with poly-iclc: Enhanced Immune Response, Improved Survival, Safety and Biomarker Identification
June 2024: Exclusive In-License of Dendritic Cell Technology
August 2024: Primary completion date for SPORE 1 combo trial at UCLA with DCvax-L and Keytruda
The share price has dropped by 83.67% from October 2020 to today. In the same period, the number of shares outstanding has increased by 50%. This indicates that while dilution has played a significant role, the share price drop is much larger than the dilution alone would suggest.
Let's calculate
Decline Scenario (Average Price $0.75):
Shares Issued: 400 million
Average Share Price: $0.75
Total Money Raised: $300 million
Rise Scenario (Average Price $3.75):
Average Share Price: $3.75
Total Money Needed to Raise: $300 million (same as in the decline scenario)
Equivalent Shares Needed: 80 million
Summary
In the Decline Scenario: NWBO issued 400 million shares at an average price of $0.75 to raise $300 million.
If the Share Price Rose from $2.51 to $5: NWBO would have only needed to issue 80 million shares at an average price of $3.75 to raise the same $300 million.
320 MILLION SHARES DILUTED EXTRA DUE TO SPOOFING!
Now who to blame for those additional 320 million shares of dilution?
Management or the market makers having spoofed the share price, because come on ... you are not that stupid that you really DO BELIEVE, that the share price of $0.41 is indicative of a free and healthy functioning financial market?
320 million shares. Wow ... that makes for a hefty su,. when damages are going to be calculated when the lawsuit goes to discovery mode.
But back to your initial calculation of what NWBO's share price should be on approval.
There's the spoofed price and the fair price.
And of course a dismissal of MTD would be changing the landscape completely regarding continuing spoofing and whether NWBO can injunction market makers trade with NWBO.
So let's just initially see, how that goes.
But we can conclude, that your $1 number of dismissal of lawsuit is at best laughable, since its premise relies on having completely forget/chosen to forget, the effect of spoofing.
And I can assure you, NWBO and LP are never going to do deals, that don't adhere to a fair measured value, where the spoofing effect has been removed from the equation.
Being a fudder yourself, I can understand where your bias comes from, not least the kind of financial incentives it is founded upon.
So specifically for our NHS, DCVAX-L will never be a widely used prescriptive treatment for Doctors here.
Nemesis18
That must be why NICE are having such great cooperation with NWBO and why british politicians in their Pathway to a Cure report from 2023 had 3 recommendations regarding brain cancer, the top two having with DCvax-L to do, recommending MHRA to approve and NICE to reimburse DCvax-L.
Must be a bitch to constantly have to promote a viewpoint that is so laughable. And even worse, to do it on a daily basis. Money is a great incentive. Speaking of being greedy.
I can recommend you to read up on the subject.
You actually MIGHT be able to gain some knowledge regarding matters you seem to have viewpoints on.
PATHWAY TO A CURE REPORT
Bullish
BULLISH
ATL-DC is DCVax-L
AI
